EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

Go back to EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies
(NASDAQ: EYEG) Delayed: 34.53 -0.12 (0.35%)
Previous Close $34.65    52 Week High $5.09 
Open $34.53    52 Week Low $1.11 
Day High $34.53    P/E N/A 
Day Low $34.53    EPS $0.00 
Volume 313